4.6 Article

CD36 Inhibitors Reduce Postprandial Hypertriglyceridemia and Protect against Diabetic Dyslipidemia and Atherosclerosis

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling

David J. Kennedy et al.

CARDIOVASCULAR RESEARCH (2011)

Article Biochemistry & Molecular Biology

Luminal Lipid Regulates CD36 Levels and Downstream Signaling to Stimulate Chylomicron Synthesis

Thi Thu Trang Tran et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Multidisciplinary Sciences

Fatty Acid- and Cholesterol Transporter Protein Expression along the Human Intestinal Tract

Christiaan J. Masson et al.

PLOS ONE (2010)

Article Biochemistry & Molecular Biology

Chylomicron remnants are increased in the postprandial state in CD36 deficiency

Daisaku Masuda et al.

JOURNAL OF LIPID RESEARCH (2009)

Article Biochemistry & Molecular Biology

Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol

Latisha Love-Gregory et al.

HUMAN MOLECULAR GENETICS (2008)

Article Biochemistry & Molecular Biology

CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice

Victor A. Drover et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Endocrinology & Metabolism

Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity

Debby P. Y. Koonen et al.

DIABETES (2007)

Article Medicine, General & Internal

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women

Sandeep Bansal et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)

Article Cardiac & Cardiovascular Systems

CD36 deficiency rescues lipotoxic cardiomyopathy

John Yang et al.

CIRCULATION RESEARCH (2007)

Article Biochemistry & Molecular Biology

Caveolin-1 is required for fatty acid translocase (FAT/CD36) localization and function at the plasma membrane of mouse embryonic fibroblasts

Axel Ring et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)

Article Biochemistry & Molecular Biology

CD36 deficiency in mice impairs lipoprotein lipase-mediated triglyceride clearance

JR Goudriaan et al.

JOURNAL OF LIPID RESEARCH (2005)

Article Hematology

Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis

M Febbraio et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)

Article Biochemistry & Molecular Biology

CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice

JR Goudriaan et al.

JOURNAL OF LIPID RESEARCH (2003)

Article Endocrinology & Metabolism

Insulin sensitivity and lipid metabolism in human CD36 deficiency

M Furuhashi et al.

DIABETES CARE (2003)

Article Medicine, Research & Experimental

Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species

EA Podrez et al.

JOURNAL OF CLINICAL INVESTIGATION (2000)

Article Medicine, Research & Experimental

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

M Febbraio et al.

JOURNAL OF CLINICAL INVESTIGATION (2000)